• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

How Monsanto Got Stung By a Zika Virus Conspiracy Theory

By
Dan Mitchell
Dan Mitchell
Down Arrow Button Icon
By
Dan Mitchell
Dan Mitchell
Down Arrow Button Icon
February 16, 2016, 3:28 PM ET
Brazil Faces New Health Epidemic As Mosquito-Borne Zika Virus Spreads Rapidly
RECIFE, BRAZIL - JANUARY 26: Grandmother Ivalda Caetano holds Ludmilla Hadassa Dias de Vasconcelos (2 months), who has microcephaly, at Oswald Cruz hospital on January 26, 2016 in Recife, Brazil. In the last four months, authorities have recorded close to 4,000 cases in Brazil in which the mosquito-borne Zika virus may have led to microcephaly in infants. The ailment results in an abnormally small head in newborns and is associated with various disorders including decreased brain development. According to the World Health Organization (WHO), the Zika virus outbreak is likely to spread throughout nearly all the Americas. At least twelve cases in the United States have now been confirmed by the CDC. The Brazilian government announced it will deploy more than 200,000 troops to combat the mosquitos which are spreading the Zika virus. (Photo by Mario Tama/Getty Images)Photograph by Mario Tama Getty Images

Over the weekend, a new theory arose and went viral, pointing fingers at a pesticide and the Monsanto Corp. in widespread cases of microcephaly in Brazil.

This happened despite a near-universal consensus among scientists and health officials that the cause is almost certainly the mosquito-borne Zika virus, and despite the fact that even if the pesticide (more precisely, a larvicide) were the cause, Monsanto has nothing to do with that product, and in fact doesn’t even manufacture larvicides.

An article published Sunday in the online publication Tech Times carried the unwieldy but ominous headline: “Larvicide Manufactured By Sumitomo, Not Zika Virus, True Cause Of Brazil’s Microcephaly Outbreak: Doctors.”

Those doctors are members of the Argentina-based group PhRed Universitária de Ambiente y Salud (University Network of Environment and Health). But based on the Tech Times article, it appears that group had little hard evidence for its conclusion that the larvicide, Pyriproxyfen, was responsible for microcephaly, which causes malformation of the heads and brains of fetuses. It is “no coincidence,” the doctors’ group asserted, that thousands of the children with the malady live near areas where the larvicide was used.

According to the Wall Street Journal, it’s not clear that such a geographical connection exists, and it’s even less clear that there’s any connection at all between the larvicide and cases of microcephaly. The doctors’ group conducted no laboratory tests and no epidemiological studies.

A state in Brazil suspended use of the larvicide as a “preventative measure” in reaction to the report, but the Brazilian government and U.S. health officials all say the report’s conclusions are unfounded. Brazil’s health ministry issued a statement saying: “Unlike the relationship between the Zika virus and microcephaly, which has had its confirmation attested in tests that indicated the presence of the virus in samples of blood, tissue and amniotic fluid, the association between the use of Pyriproxyfen and microcephaly has no scientific basis.”

An official from the U.S. National Institutes of Health called the report “sketchy.”

And what about the supposed connection to Monsanto? There’s no evidence for that either. The maker of Pyriproxyfen is the Tokyo-based Sumitomo Chemical Corp. Tech Times reported that Sumitomo is “associated with” Monsanto, and noted that the doctors’ group called Sumitomo a “subsidiary” of Monsanto.

That was enough for the story to go viral on Facebook and Twitter, spread by people who oppose the use of genetically modified seeds, a major business of Monsanto. It was further spread by such conspiracy-minded sites as NaturalNews.

After the Tech Times article was published, Monsanto issued a statement noting that the company doesn’t make larvicides, and that while it works with Sumitomo to sell herbicides and pesticides, Monsanto has nothing to do with either the Zika virus or microcephaly.

Such “misinformation causes unwarranted fear and distracts from the health crisis at hand,” the company said.

Tech Times backed off its original article with a new article in which it characterized Monsanto having ” cleared up its relationship” with Sumitomo.

There have been 41 confirmed cases of Zika-related microcephaly, and another 421 confirmed cases of microcephaly whose cause hasn’t yet been determined, according to the Brazil’s Health Ministry. Brazil said there are more than 3,800 more cases still being investigated. The World Health Organization says it expects to be able to officially establish the link between the Zika virus and microcephaly within a few weeks.

About the Author
By Dan Mitchell
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

HealthHealth
Confronting Asia’s growing rate of chronic conditions means tackling cultural issues as much as medical ones
By Stuart A. SpencerFebruary 15, 2026
7 hours ago
Susan Blumenthal
AICancer
Meet the American spies who helped mammograms save more lives
By Erik GermanFebruary 15, 2026
16 hours ago
HealthDietary Supplements
5 Best Nootropics of 2026: Expert Reviewed Supplements
By Christina SnyderFebruary 13, 2026
2 days ago
Big TechGen Z
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
2 days ago
Leesa Sapira Chill
Healthmattresses
Presidents Day Mattress Sales 2026: Find Deals on the Best Sleep Brands
By Christina SnyderFebruary 13, 2026
3 days ago
dog
CommentaryAnimals
You love your dog too much. Blame the broken American Dream and loss of purpose since the pandemic
By Margret Grebowicz and The ConversationFebruary 13, 2026
3 days ago

Most Popular

placeholder alt text
Real Estate
A billionaire and an A-list actor found refuge in a 37-home Florida neighborhood with armed guards—proof that privacy is now the ultimate luxury
By Marco Quiroz-GutierrezFebruary 15, 2026
17 hours ago
placeholder alt text
Success
Meet the grandmother living out of a 400-ft ‘granny pod’ to save money and help with child care—it’s become an American ‘economic necessity’
By Emma BurleighFebruary 15, 2026
19 hours ago
placeholder alt text
Future of Work
Malcolm Gladwell tells young people if they want a STEM degree, 'don’t go to Harvard.' You may end up at the bottom of your class and drop out
By Sasha RogelbergFebruary 14, 2026
2 days ago
placeholder alt text
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloFebruary 13, 2026
2 days ago
placeholder alt text
Economy
A U.S. 'debt spiral' could start soon as the interest rate on government borrowing is poised to exceed economic growth, budget watchdog says
By Jason MaFebruary 14, 2026
1 day ago
placeholder alt text
Big Tech
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.